nur zu Info
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
clinicaltrials.gov/ct2/show/NCT02238496?term=aezs&rank=11
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
clinicaltrials.gov/ct2/show/NCT02238496?term=aezs&rank=11